presseportal.de : Isotechnika Enrols First Patient in Phase IIb Kid...
Geschrieben von rootam 06.01.2006 22:17:02 (206 x gelesen)
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced
today that the Company enrolled its first patient in a North
American Phase IIb kidney transplant trial for its lead
immunosuppressive drug, ISA247, on January 4, 2006.
The trial ...
